Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Tax Provisions (2016 - 2024)

Arcadia Biosciences (RKDA) has disclosed Tax Provisions for 11 consecutive years, with $8000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Tax Provisions rose 14.29% year-over-year to $8000.0, compared with a TTM value of $15000.0 through Dec 2024, down 28.57%, and an annual FY2024 reading of $8000.0, changed 0.0% over the prior year.
  • Tax Provisions was $8000.0 for Q4 2024 at Arcadia Biosciences, up from $7000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $17000.0 in Q1 2020 and bottomed at -$139000.0 in Q4 2020.
  • Average Tax Provisions over 5 years is -$10444.4, with a median of $7000.0 recorded in 2023.
  • Peak annual rise in Tax Provisions hit 366.67% in 2020, while the deepest fall reached 1058.33% in 2020.
  • Year by year, Tax Provisions stood at -$139000.0 in 2020, then surged by 100.72% to $1000.0 in 2021, then surged by 1200.0% to $13000.0 in 2022, then tumbled by 46.15% to $7000.0 in 2023, then grew by 14.29% to $8000.0 in 2024.
  • Business Quant data shows Tax Provisions for RKDA at $8000.0 in Q4 2024, $7000.0 in Q4 2023, and $13000.0 in Q4 2022.